US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
The progressive neurodegenerative condition affects more than ten million people worldwide
Read More
Tag: Johns Hopkins Medicine
US study reveals interferon combinations cause lupus symptoms and affect treatment
The autoimmune disease, which affects 1.5 million people in the US, causes the body’s immune system to attack its own tissues
Read More
Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
The findings could potentially lead to new therapies and could stop the growth of cancers
Read More
Cognitive decline in early Alzheimer’s could stem from serotonin loss
MCI patients had 25% lower levels of serotonin compared to healthy patients
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
